Related Experiment Video
Updated: Jun 13, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT
Sudipan Karmakar1, Tong Gao, Margaret C Pace
1Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
Abstract:
Although the ability of coactivators to enhance the expression of estrogen receptor-alpha (ERalpha) target genes is well established, the role of corepressors in regulating 17beta-estradiol (E2)-induced gene expression is poorly understood. Previous studies revealed that the silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full ERalpha transcriptional activity in MCF-7 breast cancer cells, and we report herein the E2-dependent recruitment of SMRT to the regulatory regions of the progesterone receptor (PR) and cyclin D1 genes. Individual depletion of SMRT or steroid receptor coactivator (SRC)-3 modestly decreased E2-induced PR and cyclin D1 expression; however, simultaneous depletion revealed a cooperative effect of this coactivator and corepressor on the expression of these genes. SMRT and SRC-3 bind directly in an ERalpha-independent manner, and this interaction promotes E2-dependent SRC-3 binding to ERalpha measured by co-IP and SRC-3 recruitment to the cyclin D1 gene as measured by chromatin IP assays. Moreover, SMRT stimulates the intrinsic transcriptional activity of all of the SRC family (p160) coactivators. Our data link the SMRT corepressor directly with SRC family coactivators in positive regulation of ERalpha-dependent gene expression and, taken with the positive correlation found for SMRT and SRC-3 in human breast tumors, suggest that SMRT can promote ERalpha- and SRC-3-dependent gene expression in breast cancer.
Insights
The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor enhances estrogen receptor-alpha (ERalpha) target gene expression. SMRT cooperates with coactivators like SRC-3, promoting breast cancer gene activity.
Area of Science:
- Endocrinology
- Molecular Biology
- Cancer Research
Background:
- Coactivators enhance estrogen receptor-alpha (ERalpha) target gene expression.
- The role of corepressors in 17beta-estradiol (E2)-induced gene expression is not well understood.
- Silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) is a corepressor involved in ERalpha activity.
Purpose of the Study:
- Investigate the role of SMRT corepressor in E2-induced gene expression.
- Determine the interaction between SMRT and steroid receptor coactivator-3 (SRC-3).
- Elucidate the mechanism of SMRT and SRC-3 cooperation in ERalpha-dependent gene regulation.
Main Methods:
- Chromatin immunoprecipitation (ChIP) assays to measure SMRT and SRC-3 recruitment.
- Co-immunoprecipitation (Co-IP) to assess protein interactions.
- Gene expression analysis following SMRT or SRC-3 depletion.
Main Results:
- SMRT is recruited to progesterone receptor (PR) and cyclin D1 gene regulatory regions in an E2-dependent manner.
- SMRT and SRC-3 directly bind and cooperate to enhance E2-induced PR and cyclin D1 expression.
- SMRT enhances the transcriptional activity of SRC family coactivators.
Conclusions:
- SMRT corepressor directly interacts with SRC family coactivators to positively regulate ERalpha-dependent gene expression.
- The SMRT-SRC interaction promotes ERalpha and SRC-3-dependent gene expression in breast cancer.
- SMRT and SRC-3 show a positive correlation in human breast tumors, suggesting a role in breast cancer progression.
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
Anaphase Promoting Complex
Co-activators and Co-repressors
Co-activators and Co-repressors
Inhibition of Cdk Activity

